Flash FinanceUS
After hours S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · TuHURA Biosciences, Inc./NV (HURA)

TuHURA Biosciences draws additional $650,000 under $50 million Parkview revolving loan

Neutral Impact 2 of 5 financing Written later

TuHURA Biosciences said it borrowed an additional $650,000 on September 21, 2026, under the revolving credit facility it set up with Parkview Holdings One LLC on April 21, 2026. The facility matures on April 21, 2031, and the company expects to use the funds for general corporate purposes. The filing notes the lender is an affiliate of the company's largest stockholder and that the company may need additional capital.

Key points

  • Draw of $650,000 received and borrowed on September 21, 2026
  • Revolving credit facility with Parkview Holdings One LLC has a maximum loan availability of $50 million
  • Facility matures on April 21, 2031; funds to be used for general corporate purposes
  • Filing cites potential conflicts of interest because the lender is an affiliate of the largest stockholder

The filing

CompanyTuHURA Biosciences, Inc./NV (HURA)
Form8-K, current report
Filed with the SECSep 24, 2026, 5:00 PM ET
Accession number0001193125-26-401140

Items reported: 2.03 New Direct Financial Obligation

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 10:08 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on September 24, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.